☆ 4.7 Review

Nanomedicine-based adjuvant therapy: a promising solution for lung cancer

JOURNAL OF NANOBIOTECHNOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Radiotherapy-induced enrichment of EGF-modified doxorubicin nanoparticles enhances the therapeutic outcome of lung cancer

Jing Wang et al.

Summary: This study demonstrates promising clinical application of radiotherapy in combination with EGF@DOX-NPs for lung cancer treatment. The targeted nanoparticles selectively accumulate at the tumor site due to radiation-induced outburst of local intra-tumoral blood vessels. Compared with DOX alone, EGF@DOX-NPs significantly decrease tumor cell viability and migration, and increase apoptosis rates. Moreover, EGF@DOX-NPs increase survival of tumor-bearing mice through radiation-induced aggregation without apparent systemic toxic effects. Therefore, the combination of radiotherapy and EGF@DOX-NPs shows potential for improving clinical outcomes in lung cancer treatment.

DRUG DELIVERY (2022)

添加到收藏夹

Review Oncology

Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations

Aaron C. Tan et al.

Summary: The therapeutic landscape of non-small-cell lung cancer is undergoing significant changes with the shift from histology-based classification to molecularly defined subsets. Targeted therapies for specific driver mutations such as EGFR, ALK, and ROS1 have shown promising results, and there is a growing list of approved therapies for other mutations. The importance of diagnostic molecular testing, optimal sequencing of therapies, application of targeted therapies in early-stage disease, and the impact of genomic mutations on targeted therapy efficacy are important areas of research.

JOURNAL OF CLINICAL ONCOLOGY (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Targeted Drug/Gene/Photodynamic Therapy via a Stimuli-Responsive Dendritic-Polymer-Based Nanococktail for Treatment of EGFR-TKI-Resistant Non-Small-Cell Lung Cancer

Jinxing Huang et al.

Summary: This study proposes a nanococktail therapeutic strategy for treating EGFR-TKI resistant NSCLC by targeted co-delivery of drugs and genes, along with photodynamic therapy. The results show that this nanococktail therapy effectively releases drugs and genes at the tumor site, demonstrating potent antitumor efficacy.

ADVANCED MATERIALS (2022)

添加到收藏夹

Article Engineering, Biomedical

Engineered nanomaterials for synergistic photo-immunotherapy

Ranran Guo et al.

Summary: Nanomaterial-synergized photodynamic therapy and photothermal therapy have significant advantages in fighting cancer. Researchers are now focusing on combining these therapies with immunotherapy by using nanomaterials to promote the maturation of immune cells and infiltration of immune cells, aiming to improve the treatment effectiveness.

BIOMATERIALS (2022)

添加到收藏夹

Article Engineering, Biomedical

Tumor-Tropic Adipose-Derived Mesenchymal Stromal Cell Mediated Bi2Se3 Nano-Radiosensitizers Delivery for Targeted Radiotherapy of Non-Small Cell Lung Cancer

Jingfang Xiao et al.

Summary: Nanoparticles lack specificity to tumors, however, mesenchymal stem cells can act as delivery vehicles for nanoparticles to enhance the treatment effect. In this study, bismuth selenide nanoparticles loaded adipose-derived mesenchymal stem cells were developed for targeted radiotherapy of non-small cell lung cancer. The results demonstrate the feasibility and potential of this tumor-targeting system for radiotherapy.

ADVANCED HEALTHCARE MATERIALS (2022)

添加到收藏夹

Article Engineering, Biomedical

Precisely Targeted Nano-Controller of PD-L1 Level for Non-Small Cell Lung Cancer Spinal Metastasis Immunotherapy

Lei Zhou et al.

Summary: This study reveals the potential use of RGDyK as a new PD-L1 inhibitor and a targeting peptide for NSCLC-SM treatment. By fabricating ZnPP@MSN-RGDyK nanoparticles, efficient photodynamic therapy and immunotherapeutic effects are achieved in an NSCLC SM mouse model.

ADVANCED HEALTHCARE MATERIALS (2022)

添加到收藏夹

Review Nanoscience & Nanotechnology

Membrane-wrapped nanoparticles for photothermal cancer therapy

Sara B. Aboeleneen et al.

Summary: Cancer is a global health problem and conventional treatments are not satisfactory. Nanoparticle-mediated photothermal therapy has immense potential as a treatment for solid-tumor cancers. By camouflaging with cell membranes, light-responsive nanoparticles can play a unique role in cancer treatment and improve treatment outcomes.

NANO CONVERGENCE (2022)

添加到收藏夹

Article Engineering, Biomedical

In situ photothermal nano-vaccine based on tumor cell membrane-coated black phosphorus-Au for photo-immunotherapy of metastatic breast tumors

Deqiu Huang et al.

Summary: Cancer vaccines based on nanomaterials can trigger immunogenic cell death and provide in situ tumor-associated antigens, making them promising for the treatment of metastatic tumors. The researchers developed an in situ photothermal nano-vaccine by encapsulating immune adjuvant and inhibitor in cancer cell membrane, which selectively delivered the vaccine to the tumor site and triggered a tumor-specific immune response. The nano-vaccine also reversed the immunosuppressive tumor microenvironment, leading to enhanced tumor inhibition.

BIOMATERIALS (2022)

添加到收藏夹

Review Nanoscience & Nanotechnology

Nanotechnology: A Promising Approach for Cancer Diagnosis, Therapeutics and Theragnosis

Mesfin Dessale et al.

Summary: Cancer is the most devastating disease worldwide, and current conventional diagnostic and therapeutic methods are not efficient. Nanotechnology holds promise for quick, safe, cost-effective, and efficient cancer diagnosis and treatment, providing simultaneous diagnosis and therapy.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2022)

添加到收藏夹

Review Oncology

Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies

Hailong Tian et al.

Summary: Nanoscale drug delivery systems can effectively deliver drugs to tumor cells by targeting cell surface-specific receptors, tumor vasculature, and antigens, and stimulus-responsive nanoplatforms are considered a promising targeting strategy.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Current status of immunotherapy for non-small cell lung cancer

Tao Yang et al.

Summary: Lung cancer, especially non-small cell lung cancer (NSCLC), is still the leading cause of cancer-related deaths worldwide. Despite some clinical advancements in conventional treatments, the survival rate of NSCLC remains low. In recent years, immunotherapy, including antibody therapy and cell therapy, has emerged as a new frontier in lung cancer research, particularly immune checkpoint inhibitors (ICI). These approaches have significantly improved the survival rate and treatment response in NSCLC patients by enhancing the immune system and targeting tumor cells more effectively. This paper provides a comprehensive review of the relevant targets, clinical progress, and adverse reactions of various immunotherapies, as well as their combination therapies, aiming to offer better treatment options for NSCLC.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Novel Implications of Nanoparticle-Enhanced Radiotherapy and Brachytherapy: Z-Effect and Tumor Hypoxia

Runze Zhou et al.

Summary: This review article discusses the use of nanomaterials in radiation oncology to improve the side effects and discomfort associated with treatment. The authors explore the role of nanoparticle-enhanced radiotherapy in alleviating tumor hypoxia and delivering drugs/gene therapy.

METABOLITES (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesicles

Jing Wang et al.

Summary: The translational success of liposomes in chemotherapeutics has shown the potential of biomembrane-based nanostructures in drug delivery, while efforts are also being made in utilizing naturally derived lipid membranes for anti-cancer therapies. Despite differences in production and composition, the common phospholipid bilayer structure allows for modification and functionalization of liposomes, cell membrane-derived nanomaterials, and extracellular vesicles to combat challenges in tumor-targeted drug delivery. The review summarizes recent advancements in engineering membrane-derived nanostructures with intelligent modules for targeting tumor cells and the microenvironment in fighting malignancy, and discusses the potential of enhancing cancer therapy by combining engineered functionalities with naturally occurring activity.

ADVANCED DRUG DELIVERY REVIEWS (2021)

添加到收藏夹

Review Engineering, Biomedical

Clinical applications of nanomedicines in lung cancer treatment

Mohammad Norouzi et al.

Summary: Nanomedicines offer a new avenue for treating lung cancer, addressing issues such as lack of early diagnosis, off-target toxicity, and drug resistance associated with systemic chemotherapy. Clinical findings suggest that nanomedicines can improve pharmacokinetics and reduce systemic toxicity, potentially enhancing the outcomes of lung cancer treatment. Further investigation into the clinical applications of nanomedicines is warranted to improve clinical outcomes in lung cancer patients.

ACTA BIOMATERIALIA (2021)

添加到收藏夹

Article Engineering, Biomedical

Co-delivery of etoposide and cisplatin in dual-drug loaded nanoparticles synergistically improves chemoradiotherapy in non-small cell lung cancer models

Maofan Zhang et al.

Summary: Chemoradiotherapy with cisplatin and etoposide has shown to be effective in treating both small and non-small cell lung cancers, but with high toxicity. Utilizing nanotherapeutics in nanoparticle formulation may offer a more effective and less toxic treatment option, especially in combination chemotherapy for lung cancer.

ACTA BIOMATERIALIA (2021)

添加到收藏夹

Review Chemistry, Medicinal

Mechanisms of resistance to chemotherapy in non-small cell lung cancer

Hye-Young Min et al.

Summary: Non-small cell lung cancer (NSCLC) accounts for a majority of lung cancer cases and is typically treated with a combination of therapies, such as radiotherapy, chemotherapy, targeted therapy, and immunotherapy. However, chemoresistance remains a significant obstacle in the management of NSCLC, necessitating a better understanding of the underlying mechanisms to develop effective treatment strategies.

ARCHIVES OF PHARMACAL RESEARCH (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Nanoscience & Nanotechnology

Therapeutic efficacy of cancer vaccine adjuvanted with nanoemulsion loaded with TLR7/8 agonist in lung cancer model

Jiae Koh et al.

Summary: A cancer vaccine adjuvanted with nanoemulsion (NE) loaded with TLR7/8 agonist (R848) demonstrated robust antitumor immune responses in both subcutaneous and orthotopic mouse lung cancer models, potentially prolonging survival by activating antitumor immunity and reprogramming immunosuppression.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2021)

添加到收藏夹

Article Oncology

Radiosensitizing effect of gold nanoparticle loaded with small interfering RNA-SP1 on lung cancer AuNPs-si-SP1 regulates GZMB for radiosensitivity

Ming Zhuang et al.

Summary: This study found that AuNPs-si-SP1 can effectively absorb SP1 siRNA, be highly internalized by A549 cells to reduce SP1 protein expression, and promote cells to G2/M phase, DNA double strand breaks, and enhanced radiosensitivity, achieving radiosensitization.

TRANSLATIONAL ONCOLOGY (2021)

添加到收藏夹

Review Oncology

Neoadjuvant immunotherapy for non-small cell lung cancer: State of the art

Jin Kang et al.

Summary: The combination of immunotherapy and chemotherapy may have a significant impact on NSCLC patients, improving survival rates and treatment outcomes. There are still some challenges and unresolved issues, such as evaluating the response to immunotherapy, adjuvant treatment after neoadjuvant immunotherapy, and specific targeted therapies for cancer.

CANCER COMMUNICATIONS (2021)

添加到收藏夹

Review Medicine, General & Internal

Advances in systemic therapy for non-small cell lung cancer

Meagan Miller et al.

Summary: Lung cancer remains a leading cause of cancer-related mortality worldwide, with non-small cell lung cancer being incurable for most patients. The optimal treatment for locally advanced NSCLC includes chemoradiation, while immunotherapy can be added for unresectable cases post-chemoradiation. Advances in targeted therapies and immunotherapy have transformed the landscape of NSCLC treatment.

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Lung cancer chemotherapy using nanoparticles: Enhanced target ability of redox-responsive and pH-sensitive cisplatin prodrug and paclitaxel

Baohua Wang et al.

Summary: In this study, a GSH-responsive and pH-responsive cisplatin prodrug was synthesized and used in combination with a paclitaxel co-loaded nanoparticle system. These nanoparticles exhibited reduction and pH triggered drug release, as well as synergistic inhibition of tumor cells. In vivo studies further demonstrated high tumor distribution, low systemic toxicity, and significant anti-tumor effects, making them a promising anticancer system for the treatment of NSCLC.

BIOMEDICINE & PHARMACOTHERAPY (2021)

添加到收藏夹

Article Oncology

Phase 3 Trial Comparing Nanoparticle Albumin-Bound Paclitaxel With Docetaxel for Previously Treated Advanced NSCLC

Yasuto Yoneshima et al.

Summary: The study evaluated the efficacy and safety of nanoparticle albumin-bound paclitaxel in previously treated advanced NSCLC patients, showing noninferiority in overall survival compared to docetaxel. Furthermore, nab-paclitaxel demonstrated a higher objective response rate and longer progression-free survival.

JOURNAL OF THORACIC ONCOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach

Chang-Gon Kim et al.

Summary: Therapeutic cancer vaccines are increasingly being used in personalized cancer immunotherapy, with the aim of establishing long-lasting immune memory against tumor cells. However, challenges remain due to resistance mechanisms, and strategies such as combining immune checkpoint inhibitors are suggested to enhance vaccine efficacy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Tumor-killing nanoreactors fueled by tumor debris can enhance radiofrequency ablation therapy and boost antitumor immune responses

Zhijuan Yang et al.

Summary: The study presents a novel nanoreactor that enhances the effectiveness of RFA on tumors by suppressing residual tumors and promoting anti-tumor immunity in experimental models.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Synergy of nanodiamond-doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells

Hua-Zhen Xu et al.

Summary: The combination of Nano-DOX and BMS-1 can activate TAMs' M1-type response, inhibit tumor cell growth, and achieve synergistic therapeutic efficacy against tumors.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

添加到收藏夹

Review Materials Science, Biomaterials

Tumor microenvironment and nanotherapeutics: intruding the tumor fort

Ammu V. V. V. Ravi Kiran et al.

Summary: The recent advancements in nanomedicine have provided new approaches for diagnosing and treating tumors. However, tumor barriers can hinder drug delivery and efficacy. Strategies that target the tumor microenvironment may hold promise for improving therapeutic outcomes in cancer nanomedicine.

BIOMATERIALS SCIENCE (2021)

添加到收藏夹

Article Medicine, Research & Experimental

An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment

Chih-Hsiung Hsieh et al.

Summary: This study demonstrates the dual properties of zero-valent-iron nanoparticles (ZVI-NP) in inducing cancer-specific cytotoxicity and anti-cancer immunity, highlighting their potential as an advanced integrated anti-cancer strategy. ZVI-NP not only induces cancer cell death but also enhances the anti-tumor immune response in animal models.

THERANOSTICS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Melatonin enhances radiofrequency-induced NK antitumor immunity, causing cancer metabolism reprogramming and inhibition of multiple pulmonary tumor development

Ming Li et al.

Summary: The combined treatment of local radiofrequency ablation (RFA) and melatonin (MLT) significantly improves clinical outcomes for early lung cancer patients with multiple pulmonary nodules by minimizing lung function injury and reducing the probability of malignant transformation or enlargement of nodules in non-ablated areas. RFA effectively removes treated tumors and stimulates antitumor immunity, while MLT enhances RFA-stimulated NK activity and exerts synergistic antitumor effects. The combined treatment changes tumor metabolism, inhibits tumor growth, and provides an innovative non-invasive strategy for treating early lung tumors with multiple pulmonary nodules.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

添加到收藏夹

Review Materials Science, Biomaterials

Platinum-based chemotherapy via nanocarriers and co-delivery of multiple drugs

Caihong Xian et al.

Summary: Platinum-based anticancer drugs inhibit cancer cell growth by disrupting DNA replication, making them widely used in clinics. However, their successful application is limited due to drug resistance and side effects. Strategies such as nanocarriers and multicomponent chemotherapy have been used to address these challenges.

BIOMATERIALS SCIENCE (2021)

添加到收藏夹

Article Materials Science, Biomaterials

Cisplatin nanoparticles boost abscopal effect of radiation plus anti-PD1 therapy

Ying Wang et al.

Summary: CDDP-NPs enhance the abscopal effect of radiation therapy by increasing the CD8(+) T cell population, promoting immunogenic cell death, and facilitating CD8(+) T cell infiltration. Additionally, CDDP-NPs induce chemokine secretion, leading to enhanced CD8(+) T cell infiltration in non-irradiated tumors. This study demonstrates the potential of CDDP-NPs in boosting immune activation and overcoming the efficiency limitation of the abscopal effect induced by radiation therapy combined with anti-PD1.

BIOMATERIALS SCIENCE (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles

Aixue Li et al.

Summary: Nanotechnology provides synthetic carriers for cancer drug delivery, while cell-derived biomimetic vehicles based on the concept of 'mimicking nature' offer low immunogenicity, long circulation time, and targeting ability. Cell membrane-coated carriers and extracellular vesicles are two widely used cell-based biomimetic materials in targeted cancer therapy, but they also face future challenges and development prospects.

DRUG DELIVERY (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Clinical applications of nanomedicine in cancer therapy

Mohammad Norouzi et al.

DRUG DISCOVERY TODAY (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Drug resistance to targeted therapeutic strategies in non-small cell lung cancer

Wen-juan Liu et al.

PHARMACOLOGY & THERAPEUTICS (2020)

添加到收藏夹

Article Engineering, Biomedical

Degradation-regulated architecture of injectable smart hydrogels enhances humoral immune response and potentiates antitumor activity in human lung carcinoma

Huu Thuy Trang Duong et al.

BIOMATERIALS (2020)

添加到收藏夹

Article Engineering, Environmental

HIF-1 dependent reversal of cisplatin resistance via anti-oxidative nano selenium for effective cancer therapy

Xiaojuan Zhang et al.

CHEMICAL ENGINEERING JOURNAL (2020)

添加到收藏夹

Review Chemistry, Multidisciplinary

Functional black phosphorus nanosheets for cancer therapy

Li Qin et al.

JOURNAL OF CONTROLLED RELEASE (2020)

添加到收藏夹

Review Chemistry, Multidisciplinary

Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies

A. C. Marques et al.

JOURNAL OF CONTROLLED RELEASE (2020)

添加到收藏夹

Review Oncology

RFA of primary and metastatic lung tumors: long-term results

Stefano Giusto Picchi et al.

MEDICAL ONCOLOGY (2020)

添加到收藏夹

Review Respiratory System

Conquering lung cancer: current status and prospects for the future

R. Pirker

PULMONOLOGY (2020)

添加到收藏夹

Review Cell Biology

CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer

Maria Auxiliadora Olivares-Urbano et al.

CELLS (2020)

添加到收藏夹

Review Chemistry, Multidisciplinary

Engineered Nanoparticles for Cancer Vaccination and Immunotherapy

Marisa E. Aikins et al.

ACCOUNTS OF CHEMICAL RESEARCH (2020)

添加到收藏夹

Review Respiratory System

Radiotherapy treatment for lung cancer: Current status and future directions

Shalini K. Vinod et al.

RESPIROLOGY (2020)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Effects of Selenium Nanoparticles Combined With Radiotherapy on Lung Cancer Cells

Jingxia Tian et al.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)

添加到收藏夹

Review Nanoscience & Nanotechnology

Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy

Yao Chen et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)

添加到收藏夹

Review Chemistry, Multidisciplinary

Mechanisms for Tuning Engineered Nanomaterials to Enhance Radiation Therapy of Cancer

Sandhya Clement et al.

ADVANCED SCIENCE (2020)

添加到收藏夹

Article Chemistry, Multidisciplinary

Immunogenic exosome-encapsulated black phosphorus nanoparticles as an effective anticancer photo-nanovaccine

Quan Liu et al.

NANOSCALE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Targeting folate receptor β positive tumor-associated macrophages in lung cancer with a folate-modified liposomal complex

Tie Yan et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy

Qianmei Yang et al.

THERANOSTICS (2020)

添加到收藏夹

Review Immunology

Tumour-intrinsic resistance to immune checkpoint blockade

Anusha Kalbasi et al.

NATURE REVIEWS IMMUNOLOGY (2020)

添加到收藏夹

Review Chemistry, Multidisciplinary

Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer

Yijing Liu et al.

CHEMICAL SOCIETY REVIEWS (2019)

添加到收藏夹

Article Critical Care Medicine

A Novel Laser Fiberscope for Simultaneous Imaging and Phototherapy of Peripheral Lung Cancer

Tomonari Kinoshita et al.

CHEST (2019)

添加到收藏夹

Review Oncology

Emerging therapies for small cell lung cancer

Sen Yang et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

添加到收藏夹

Article Engineering, Biomedical

Effects of gold nanoprism-assisted human PD-L1 siRNA on both gene down-regulation and photothermal therapy on lung cancer

Bin Liu et al.

ACTA BIOMATERIALIA (2019)

添加到收藏夹

Article Chemistry, Multidisciplinary

Combretastatin A4 Nanodrug-Induced MMP9 Amplification Boosts Tumor-Selective Release of Doxorubicin Prodrug

Jian Jiang et al.

ADVANCED MATERIALS (2019)

添加到收藏夹

Review Oncology

The evolving landscape of immunotherapy in small-cell lung cancer: A focus on predictive biomarkers

Francesco Gelsomino et al.

CANCER TREATMENT REVIEWS (2019)

添加到收藏夹

Article Medicine, General & Internal

Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz-Ares et al.

LANCET (2019)

添加到收藏夹

Article Chemistry, Multidisciplinary

Peptide Nanotube-Templated Biomineralization of Cu2-xS Nanoparticles for Combination Treatment of Metastatic Tumor

Yi Lai et al.

SMALL (2019)

添加到收藏夹

Article Immunology

TLR9 agonist enhances radiofrequency ablation-induced CTL responses, leading to the potent inhibition of primary tumor growth and lung metastasis

Aizhang Xu et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2019)

添加到收藏夹

Review Chemistry, Multidisciplinary

Recent Advances in Cell Membrane-Camouflaged Nanoparticles for Cancer Phototherapy

Xu Zhen et al.

SMALL (2019)

添加到收藏夹

Review Oncology

Improving cancer immunotherapy through nanotechnology

Michael S. Goldberg

NATURE REVIEWS CANCER (2019)

添加到收藏夹

Article Medicine, General & Internal

Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer

Johannes Uhlig et al.

JAMA NETWORK OPEN (2019)

添加到收藏夹

Article Materials Science, Biomaterials

Construction of DOX/APC co-loaded BiOI@CuS NPs for safe and highly effective CT imaging and chemo-photothermal therapy of lung cancer

Ying Zhang et al.

JOURNAL OF MATERIALS CHEMISTRY B (2019)

添加到收藏夹

Review Medicine, Research & Experimental

Photodynamic therapy - mechanisms, photosensitizers and combinations

Stanislaw Kwiatkowski et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

添加到收藏夹

Article Surgery

Long-term results of CT-guided percutaneous radiofrequency ablation of inoperable patients with stage Ia non-small cell lung cancer: A retrospective cohort study

Bing-Yang Huang et al.

INTERNATIONAL JOURNAL OF SURGERY (2018)

添加到收藏夹

Article Medicine, Research & Experimental

Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system

Siwen Li et al.

THERANOSTICS (2018)

添加到收藏夹

Review Materials Science, Biomaterials

Recent progress in the development of near-infrared organic photothermal and photodynamic nanotherapeutics

Houjuan Zhu et al.

BIOMATERIALS SCIENCE (2018)

添加到收藏夹

Review Oncology

Fundamental Mechanisms of Immune Checkpoint Blockade Therapy

Spencer C. Wei et al.

CANCER DISCOVERY (2018)

添加到收藏夹

Article Chemistry, Medicinal

Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid-polymer hybrid nanopartices

Jia Liu et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Radiotherapy induces responses of lung cancer to CTLA-4 blockade

Silvia C. Formenti et al.

NATURE MEDICINE (2018)

添加到收藏夹

Review Multidisciplinary Sciences

The biology and management of non-small cell lung cancer

Roy S. Herbst et al.

NATURE (2018)

添加到收藏夹

Article Nanoscience & Nanotechnology

Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides

Jiawei Sun et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)

添加到收藏夹

Article Chemistry, Multidisciplinary

Optimized biodegradable polymeric reservoir-mediated local and sustained co-delivery of dendritic cells and oncolytic adenovirus co-expressing IL-12 and GM-CSF for cancer immunotherapy

Eonju Oh et al.

JOURNAL OF CONTROLLED RELEASE (2017)

添加到收藏夹

Article Nanoscience & Nanotechnology

Milk-derived exosomes for oral delivery of paclitaxel

Ashish K. Agrawal et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)

添加到收藏夹

Review Oncology

Cancer nanomedicine: progress, challenges and opportunities

Jinjun Shi et al.

NATURE REVIEWS CANCER (2017)

添加到收藏夹

Article Biochemical Research Methods

Erythrocyte Membrane-Wrapped pH Sensitive Polymeric Nanoparticles for Non-Small Cell Lung Cancer Therapy

Lipeng Gao et al.

BIOCONJUGATE CHEMISTRY (2017)

添加到收藏夹

Review Chemistry, Multidisciplinary

Emerging Nanotechnology and Advanced Materials for Cancer Radiation Therapy

Guosheng Song et al.

ADVANCED MATERIALS (2017)

添加到收藏夹

Review Respiratory System

Immunotherapy for lung cancer

Antonius Steven et al.

RESPIROLOGY (2016)

添加到收藏夹

Article Chemistry, Multidisciplinary

Quantitative Proteomic Analysis of Cellular Resistance to the Nanoparticle Abraxane

Minzhi Zhao et al.

ACS NANO (2015)

添加到收藏夹

Article Chemistry, Multidisciplinary

X-ray Radiation-Controlled NO-Release for On-Demand Depth-Independent Hypoxic Radiosensitization

Wenpei Fan et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)

添加到收藏夹

Article Engineering, Biomedical

Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response

Lei Jiang et al.

BIOMATERIALS (2015)

添加到收藏夹

Review Chemistry, Multidisciplinary

Improving drug delivery to solid tumors: Priming the tumor microenvironment

Iftikhar Ali Khawar et al.

JOURNAL OF CONTROLLED RELEASE (2015)

添加到收藏夹

Review Nanoscience & Nanotechnology

Applications of polymer micelles for imaging and drug delivery

Sara Movassaghian et al.

WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2015)

添加到收藏夹

Review Medicine, General & Internal

Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data

Sarah Burdett et al.

LANCET (2014)

添加到收藏夹

Article Multidisciplinary Sciences

Comprehensive molecular profiling of lung adenocarcinoma

Eric A. Collisson et al.

NATURE (2014)

添加到收藏夹

Article Engineering, Biomedical

Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways

Nan Li et al.

BIOMATERIALS (2013)

添加到收藏夹

Review Chemistry, Multidisciplinary

nab-Paclitaxel mechanisms of action and delivery

Denise A. Yardley

JOURNAL OF CONTROLLED RELEASE (2013)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Radiofrequency ablation for single lung tumours not suitable for surgery: seven years' experience

G. Carrafiello et al.

RADIOLOGIA MEDICA (2012)

添加到收藏夹

Review Medicine, General & Internal

Molecular origins of cancer: Lung cancer

Roy S. Herbst et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

添加到收藏夹

Review Pharmacology & Pharmacy

Albumin-bound paclitaxel: a next-generation taxane

William J. Gradishar

EXPERT OPINION ON PHARMACOTHERAPY (2006)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.